{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:17:48Z","timestamp":1771395468948,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although systemic corticosteroids remain the mainstay of therapy for idiopathic sudden sensorineural hearing loss (SSNHL), evidence of adherence to standardized treatment algorithms and their impact on hearing outcomes is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of a prospectively collected multicenter cohort comprising one university hospital, 16 affiliated hospitals, and two community clinics in Nagano Prefecture, Japan (2018\u20132024). Consecutive patients diagnosed with SSNHL were treated according to a unified algorithm derived from national epidemiological surveys. Adherence was defined as compliance with the initial and salvage therapies specified in the algorithm, and hearing outcomes were evaluated using the five-frequency pure-tone average (250\u20134,000 Hz) according to national criteria. Multivariable logistic regression with robust standard errors was used to identify determinants of adherence and factors associated with marked recovery (\u226530 dB improvement).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall adherence rate was 60.3% among 373 patients. Non-adherence was more prevalent in severe cases (Grade \u22653), among older patients (\u226565 years), individuals with diabetes, and secondary referrals. Adherent cases showed better final hearing recovery than non-adherent ones (47.7% vs. 31.3%,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.01). In cases of Grade \u22653, intravenous steroid therapy during initial treatment yielded greater early improvement than oral therapy (Grade 3: 46.0% vs. 25.0%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.018); however, there was no significant difference in final outcomes. Of the 110 patients requiring salvage treatment, intratympanic steroid injection was performed in 51.8% and was independently associated with superior recovery vs. observation (adjusted odds ratio, 14.35; 95% confidence interval, 1.60\u2013128.42;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.017).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this multicenter cohort, adherence to a standardized algorithm was moderate but was associated with improved hearing outcomes. In severe SSNHL, intravenous steroids enhance the early response\u2014most notably in Grade 3\u2014while salvage intratympanic steroid therapy considerably improves the final recovery rate. These findings support the implementation and optimization of the algorithm as well as the refinement of systemic dosing. Additionally, they highlight the importance of structured, guideline-based management in routine practice to improve outcomes in real-world SSNHL care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1775755","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:33:11Z","timestamp":1771392791000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical impact of adherence to a standardized treatment algorithm for idiopathic sudden sensorineural hearing loss: a multicenter cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Ryosuke","family":"Kitoh","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology\u2013Head and Neck Surgery, Shinshu University School of Medicine","place":["Matsumoto, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takumi","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology\u2013Head and Neck Surgery, Shinshu University School of Medicine","place":["Matsumoto, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","article-title":"Ministry of Health, Labour and Welfare Research Group on Intractable Hearing Disorders","volume-title":"Clinical Practice Guidelines for the Diagnosis and Management of Acute Sensorineural Hearing Loss 2018","author":"Japan","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.anl.2024.06.004","article-title":"Clinical practice guidelines for the diagnosis and management of acute sensorineural hearing loss","volume":"51","author":"Kitoh","year":"2024","journal-title":"Auris Nasus Larynx"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599819859885","article-title":"Clinical practice guideline: sudden hearing loss (update)","volume":"161","author":"Chandrasekhar","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B4","year":"2018","journal-title":"Hearing Loss in Adults: Assessment and Management"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1080\/00016489.2017.1297537","article-title":"Nationwide epidemiological survey of idiopathic sudden sensorineural hearing loss in Japan","volume":"137","author":"Kitoh","year":"2017","journal-title":"Acta Otolaryngol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/00016489.2019.1687936","article-title":"Treatment algorithm for idiopathic sudden sensorineural hearing loss based on epidemiologic surveys of a large Japanese cohort","volume":"140","author":"Kitoh","year":"2020","journal-title":"Acta Otolaryngol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1177\/0194599820922155","article-title":"Adherence to American Academy of Otolaryngology\u2013head and neck surgery clinical practice guidelines: a systematic review","volume":"163","author":"Ryan","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1080\/00016489.2017.1296970","article-title":"The effect of initial treatment on hearing prognosis in idiopathic sudden sensorineural hearing loss: a nationwide survey in Japan","volume":"137","author":"Okada","year":"2017","journal-title":"Acta Otolaryngol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5631\/jibirin.108.267","article-title":"The evaluation of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss","volume":"108","author":"Kitoh","year":"2015","journal-title":"Practica Oto-Rhino-Laryngologica"},{"key":"B10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0194599816650175","article-title":"Evaluation of compliance for treatment of sudden hearing loss: a CHEER network study","volume":"155","author":"Witsell","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/0194599818768511","article-title":"Sudden sensorineural hearing loss in the department of defense","volume":"159","author":"Hughes","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40463-017-0207-1","article-title":"Predictors of hearing recovery in patients with severe sudden sensorineural hearing loss","volume":"46","author":"Weiss","year":"2017","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/00016489.2020.1842493","article-title":"Therapeutic efficacy of super-high-dose steroid therapy in patients with profound sudden sensorineural hearing loss: a comparison with conventional steroid therapy","volume":"141","author":"Song","year":"2021","journal-title":"Acta Otolaryngol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5152\/B-ENT.2024.231261","article-title":"An analysis of systemic steroid dosage in idiopathic sudden sensorineural hearing loss","volume":"20","author":"Hyakusoku","year":"2024","journal-title":"B-ENT"},{"key":"B15","doi-asserted-by":"publisher","first-page":"EVIDoa2300172","DOI":"10.1056\/EVIDoa2300172","article-title":"High-dose glucocorticoids for the treatment of sudden hearing loss","volume":"3","author":"Plontke","year":"2023","journal-title":"NEJM Evid"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00405-015-3689-3","article-title":"Intratympanic corticosteroid injections: a systematic review of literature","volume":"273","author":"Lavigne","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.bjorl.2015.06.007","article-title":"Intratympanic corticosteroid for sudden hearing loss: does it really work?","volume":"82","author":"Barreto","year":"2016","journal-title":"Braz J Otorhinolaryngol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e08955","DOI":"10.1016\/j.heliyon.2022.e08955","article-title":"Intratympanic corticosteroid as salvage therapy in treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis","volume":"8","author":"Devantier","year":"2022","journal-title":"Heliyon"},{"key":"B19","doi-asserted-by":"publisher","first-page":"CD008080","DOI":"10.1002\/14651858.CD008080.pub2","article-title":"Intratympanic corticosteroids for sudden sensorineural hearing loss","volume":"7","author":"Plontke","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/MAO.0b013e318238fc43","article-title":"Intratympanic dexamethasone is an effective method as a salvage treatment in refractory sudden hearing loss","volume":"32","author":"Moon","year":"2011","journal-title":"Otol Neurotol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.5631\/jibirin.117.961","article-title":"Intratympanic steroid injection for idiopathic SSNHL","volume":"117","author":"Kitoh","year":"2024","journal-title":"Practica Oto-Rhino-Laryngologica"},{"key":"B22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/01945998211012300","article-title":"Tympanic membrane perforation after intratympanic steroid injection: a systematic review and meta-analysis","volume":"166","author":"Kim","year":"2022","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1775755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:33:13Z","timestamp":1771392793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1775755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":22,"alternative-id":["10.3389\/fneur.2026.1775755"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1775755","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1775755"}}